Healio Coverage

February 21, 2021
1 min read

Exchangeable IOLs top recent ophthalmic business news


Healio Coverage

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

The most popular ophthalmic business items so far this year include a discussion on exchangeable IOLs and the announcement of a research agreement.

Check out some recent ophthalmic business news items below:

Exchangeable IOLs may be option for presbyopia management

Easily exchangeable IOLs and more advanced accommodating IOLs may be on the horizon for presbyopia management, according to speakers on the clinical panel at the virtual Ophthalmology Innovation Summit Presbyopia Innovation Showcase. Read more.

BLOG: What new ophthalmologists will know that we did not

Standards for care in keratoconus have been changing rapidly. As today’s residents and fellows prepare to enter practice, they will have a completely different perspective on this disease than ophthalmologists who are more experienced. Read more.

Verana Health, Janssen enter research agreement

Verana Health and Janssen have entered into a research collaboration agreement focusing on ophthalmology and urology. Read more.

Ocumension makes $15.7 million equity investment in EyePoint

EyePoint Pharmaceuticals received a $15.7 million equity investment from Ocumension Therapeutics. Read more.

VIDEO: Glaukos discusses recent study results with iDose TR, iStent infinite

In this video perspective, Joseph Gilliam, chief financial officer and senior vice president of corporate development at Glaukos, discusses the latest news on the iDose TR and iStent infinite. Watch here.